Use of local corticosteroid injections in supraspinatus tendinitis

Date First Published:
August 10, 2000
Last Updated:
June 8, 2005
Report by:
Walid Alsalim, Specialist Registrar in Emergency Medicine (Ipswich Hospital)
Search checked by:
Liz Allen, Ipswich Hospital
Three-Part Question:
In [patients presenting with supraspinatus tendinitis] does [local steroid injection] [relieve pain and reduce time to recovery]
Clinical Scenario:
A 56 year old lady present in Emergency Department with a history of severe pain in his right shoulder following a busy day working in his garden. She had pain on resisted abduction and tenderness over supraspinatus tendon.
Search Strategy:
Medline 1951-May 2005 using dialog (datastar)
Search Details:
[supraspinatus or tendonitis] AND [glucocorticoids#.W.DE. or methylprednisolone#.W.DE. or triamcinolone acetonide#.W.DE] AND [injection$]
Outcome:
45 papers were identified of which 3 were relevant and formed the subject of this review.
Relevant Paper(s):
Study Title Patient Group Study type (level of evidence) Outcomes Key results Study Weaknesses
Subacromial Triamcinolone Hexacetonide and Methylprednisolone Injections in Treatment of Supraspinam Tendinitis. Valtonen EJ. 1976 Finland 60 patients in outpatient (Rheumatology clinic) with supraspinatus tendonitis
Comparing triamcinolon acetonide versus methyl-Prednisolone
Clinical trial Pain at 8 weeks Triam. 3.83 to 1.41 p 0.001. Methyl 3.77 to 1.55 p 0.001. Triam 50% vs mthyl 41% NS between two drugs in reducing pain. No randomisation
No power calculation
Not blinded
Not in ED setting
Side effects: Triam was more painful than methylprednisolone
33% triam required 2nd injection versus 63% in meth. Arm.
Localised tenderness at 8 weeks Triam 3.30 to 0.96 p 0.001. Methyl 3.17 to 0.45 p 0.01. Triam 29% vs methyl 14%. NS between two drugs.
Limitation of motion Triam 2.90 to 0.78 p 0.001. Methyl 3.13 to 0.85 p 0.001. Triam 27% vs 27%. NS between two drugs.
Disturbance of sleep Triam 3.33 to 1.17 p 0.001. Methyl 3.37 to 1.20 p 0.001. Triam 35% vs methyl 36%. NS between two drugs.
Double Acting Betamethasone (Celestone Chonodose) in the Treatment of Supraspinatus Tendinitis. Valtonen EJ. 1978 Finland 180patients
A- 90 pts received local injection of 6 mg betamethasone
B- 60 pts intramuscular 6 mg betamethasone
C- 30 pts received IM saline
Comparing subacromial and gluteal single injection with placebo
Clinical trial Pain relief, functional improvement at 1, 2, 4 weeks. Diff A-B At (1) week: NS. At (2) week: NS. At (4) week: NS. Not randomised
Not powered
Loss of follow up
Diff A-C At (1) week: 0.01<p<0.02. At (2) week: 0.01<p<0.05. At (4)week:NS.
A Placebo-Controlled Trial of Steroid Injections in the Treatment of Supraspinatus Tendonitis. Withrington R H, Girgis F L, Seifert M H. 1985 England 25 pts Rheumatology clinic
Group 1 -12 pts received local injection of 80 mg (2ml) methyl prednisolone plus 2ml of 2% lignocaine.
Group 2 -13 pts received 4 mls of 0.09% Nacl
Clinical trial Shoulder movements and pain assessment at presentation 2 weeks and 8 weeks. Group 1. 7 pts responded at (2) weeks (two relapsed at 8 weeks). Mean improvements in VAS of 3.71 cm between (0) and (20 weeks) P > 0.05 Small trial
Not powered
Placebo vs methylpred. and local effect
Group 2. 4 pts responded at (2) weeks (1 pt relapsed at 8 weeks). Mean improvement in VAS of 1.16 cm at (0) and (2) weeks. P > 0.05
Author Commentary:
Only three studies were found of which all go back to mid-seventies. They were of low quality to produce evidence supporting this clinical practice.
Bottom Line:
Local hospital policy to be followed regarding the treatment of this clinical condition.
References:
  1. Valtonen EJ.. Subacromial Triamcinolone Hexacetonide and Methylprednisolone Injections in Treatment of Supraspinam Tendinitis.
  2. Valtonen EJ.. Double Acting Betamethasone (Celestone Chonodose) in the Treatment of Supraspinatus Tendinitis.
  3. Withrington R H, Girgis F L, Seifert M H.. A Placebo-Controlled Trial of Steroid Injections in the Treatment of Supraspinatus Tendonitis.